|
Volumn 35, Issue 1, 2007, Pages 22-25
|
Alcohol and the liver
|
Author keywords
alcoholic cirrhosis; alcoholic fatty liver; alcoholic hepatitis; alcoholic liver disease
|
Indexed keywords
ACAMPROSATE;
ACETALDEHYDE;
BILIRUBIN;
CORTICOSTEROID;
NALTREXONE;
PENTOXIFYLLINE;
PREDNISOLONE;
TUMOR NECROSIS FACTOR ALPHA;
ALCOHOL ABSTINENCE;
ALCOHOL CONSUMPTION;
ALCOHOL LIVER CIRRHOSIS;
ALCOHOL LIVER DISEASE;
ALCOHOLIC FATTY LIVER;
ALCOHOLISM;
BILIRUBIN BLOOD LEVEL;
CELL DEATH;
CLINICAL FEATURE;
COUNSELING;
CYTOKINE RELEASE;
DISEASE COURSE;
DRUG CONTRAINDICATION;
ENDOPLASMIC RETICULUM;
ENDOTOXEMIA;
FATTY ACID SYNTHESIS;
FIBROGENESIS;
GLUCOSE INTOLERANCE;
HEPATIC ENCEPHALOPATHY;
HEPATITIS;
HUMAN;
INCIDENTAL FINDING;
LIVER CELL CARCINOMA;
LIVER FAILURE;
LIVER FIBROSIS;
LIVER FUNCTION TEST;
LIVER INJURY;
LIVER TRANSPLANTATION;
MORTALITY;
OBESITY;
OXIDATIVE STRESS;
PATHOGENESIS;
PORTAL HYPERTENSION;
PRIORITY JOURNAL;
PROGNOSIS;
REVIEW;
RISK FACTOR;
SEX DIFFERENCE;
SURVIVAL TIME;
UNITED KINGDOM;
|
EID: 33845541627
PISSN: 13573039
EISSN: None
Source Type: Journal
DOI: 10.1053/j.mpmed.2006.10.003 Document Type: Review |
Times cited : (7)
|
References (8)
|